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Abstract
Background: In recent years, rotavirus genotyping by RT-PCR has provided valuable information
about the diversity of rotaviruses (RV) circulating throughout the world.
The purpose of the present study was to monitor the prevalence of the different G and P genotypes
of rotaviruses circulating in Salento and detect any uncommon or novel types.
Methods: During the period from January 2006 to December 2007, a total of 243 rotavirus
positive stool samples were collected from children with diarrhoea admitted to four Hospitals in
the province of Lecce (Copertino, Galatina, Gallipoli and Tricase).
All the specimens were tested for RV by real time PCR and genotyped for VP7 (G-type) and VP4
(P-type) gene by reverse transcription (RT) and multiplex PCR using different type specific primers.
Results: In course of this study we identified 4 common G&P combinations viz. G2P[8], G1P[8],
G2P[4] and G9P[8] amongst 59.8% of the typeable rotavirus positives.
Rotavirus G2P[8] was recognized as the most widespread genotype during the sentinel-based
survey in Salento.
The detection of other novel and unusual strains, such as G2P[10], G4P[10], G8P[4], G9P[11] and
G10P[8] is noteworthy.
Furthermore, a significant number of mixed infections were observed during the survey period but
G3P[8] rotaviruses were not detected.
Conclusion: This study highlights the genetic diversity among rotaviruses isolated from children
in Salento and the emergence of some novel strains. Therefore, it is highly essential to continuously
monitor for these strains so as to assess the impact of vaccines on RV strains circulating in Salento
and understand the effect of strain variation on efficacy of presently available vaccines.
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Background
Rotavirus (RV), the most common cause of gastroenteritis
in infants and young children, presents a capsid formed
by three concentric layers. The outer protein layer is com-
posed of VP4 and VP7, the two major antigens of the
virus, and the middle layer is composed of VP6 molecules
arranged as trimers. The central core is composed mainly
of VP2 and contains 11 segments of double-stranded RNA
and enzyme complexes responsible for the processes of
RNA transcription and replication [1].
As the two gene segments that encode the outer capsid
proteins (VP4 and VP7) segregate independently, a typing
system consisting of both G and P genotypes has been
developed. To date, 15 G and 26 P genotypes have been
described [2,3].
The segmented nature of the RV genome provides an
opportunity for genetic reassortment, or plays an impor-
tant role in rotavirus diversity through genetic shift as
demonstrated by many authors [4,5].
Worldwide surveillance of RV strains has demonstrated
G1 to G4 genotypes with P[8] and P[4] genotypes to be
the most common circulating RV [5,6]. However, several
recent international studies have reported some unusual
types (G5, G8 and G12) and rare combinations of G and
P types [6-10].
G12 strains, in particular, had been detected during the
previous study in 2004 in Salento and nucleotide
sequences were deposited in database with accession
numbers EF536025 and EF536026 respectively [11].
Surveillance studies and documentation of rotavirus G
and P genotypes is necessary for comprehensive evalua-
tion of evolution of new strains and assessing the capabil-
ity of vaccines to provide heterotypic protection.
The objective of this study was to monitor the prevalence
of the different G and P types circulating in Salento and to
detect uncommon and novel types.
This report highlights the results gathered during the
ongoing sentinel-based network surveillance in hospitals
of Salento having a paediatric ward, since 2004, to under-
stand the molecular epidemiological changes amongst
rotaviruses in relation to their G and P genotypes [12].
Methods
From January 2006 to December 2007, a total of 243 rota-
virus-positive stool specimens were collected during the
course of treatment from children under 16 years of age
hospitalized with gastro-enteric symptoms in four hospi-
tals in the province of Lecce, specifically Copertino,
Galatina, Gallipoli and Tricase.
The routine diagnosis for RV infection was carried out in
the Clinical Virology Laboratories of the hospitals by
means of rapid screening tests currently available in the
market, such as latex agglutination (ROTAGEN, Biokit)
and immuno-chromatographic (ROTA-STRIP QUICK-
TEST, Amplimedical) tests. According to the producers,
these tests have a sensitivity and specificity ranging
between 95.7–100% and 96.3–100%, respectively. RV-
positive specimens were collected anonymously in com-
pliance with the Helsinki Declaration and with the Law
Decree n. 196/2003, article 24 (Code for the protection of
personal data). Furthermore, in this study was not per-
formed any experimental work on patients, therefore the
Ethics Committee of Ferrara (Italy) declared that this form
of study doesn't need any consent by the Ethic Committee
in compliance with the Italian Law.
The specimens were stored at -20°C until tested by molec-
ular biology techniques.
The faecal samples (0.5–1 ml) were diluted to approx. 5
ml of 0.89% NaCl; centrifugated for 20 min at 3000 rpm
and filtered using a 0.22 μm filter.
Rotavirus double-stranded RNA was extracted using the
QIAamp Viral RNA kit (QIAGEN AG, Basel, Switzerland)
according to the manufacturer's instructions.
The RNA was retro-transcribed and amplified by real-time
PCR (Fastset Rotavirus; Arrows Diagnostics, Italy).
Table 1: The genotype nature of RV positive specimens
Year Rotavirus positive specimens minus untypeable Only G typed Only P typed G & P typed
Single Mixed Single Mixed Single Mixed *
2006 108-3 = 105 17 4 3 - 59 22
2007 135-4 = 131 19 4 1 - 93 14
2006–2007 243-7 = 236 36 8 4 - 152 36
* Gmixed-P; G-Pmixed and Gmixed-Pmixed.
RV positive specimens which were G typed and/or P typed (single or mixed types) during 2006–2007BMC Infectious Diseases 2009, 9:43 http://www.biomedcentral.com/1471-2334/9/43
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Reverse transcription with random primers and G and P
typing semi-nested multiplex PCR were performed as
described previously by Iturriza-Gomara et al [13].
The consensus primers (VP7-F/VP7-R and con2/con3)
were used in multiplex first round reactions and type-spe-
cific primers (G1–G4, G8–G10 and P[4], P[6], P[8]–
P[11]) were used in the second round reactions.
All the RT-PCRs were performed with viral RNA extracted
from reference samples as positive controls and RNase
free water as negative control.
RT-PCR fragments were electrophoresed in 2% agarose
gels in Tris-borate-EDTA buffer along with a 100-bp or 50-
bp DNA ladder (PROMEGA) as a standard marker. The
gels were stained with ethidium bromide and amplicons
were viewed with UV light.
Results
A total of 243 stool samples were collected from children
with acute gastroenteritis during 2006 (n = 108) and 2007
(n = 135).
All samples screened were found to be rotavirus positive
by real time PCR. Among these 7 specimens were non
typeable (i.e., neither a G nor a P genotype could be iden-
tified) by multiplex-PCR. Forty-eight samples were par-
tially typed (i.e., only one of the two genotypic
specificities was obtained; in 44 samples, no P type could
be identified, and in 4 samples, no G type was identified).
A total of 188 specimens were characterized according to
G and P specificities (152 = G&P single typed and 36 =
G&P mixed typed) (Table 1).
RV genotypes G1 and G2, were observed to be widely cir-
culating in Salento, with overall incidences of 21.4%,
44.9%, respectively. G4 (3.7%) and G9 (7.4%) strains
were detected less frequently. Additionally, for the first
time in Salento and only in 2006, G8 (0.4%, i.e. 1/243)
and G10 (0.4%, i.e. 1/243) strains were detected. The G-
type distribution in each year is described in figure 1.
Among the P-types, P[4] and P[8] accounted for 19.7%
and 48.5% of the total samples, respectively. Even in this
case, we identified uncommon genotypes, such as P[9],
P[10] and P[11] with overall incidences of 1.6% (4/243),
5.8% (14/243) and 0.4% (1/243), respectively. Instead,
RV genotype P[6] was detected in three samples only in
2006 (Figure 2).
Totally, fifteen G/P combinations were identified, and the
most common RV strains were G2P[8], G1P[8], G2P[4]
and G9P[8] with prevalence of 25.7%, 24.3%, 23% and
9.9% of the typeable RV samples (n = 152), respectively.
Less common types were G4P[8], G1P[9], G4P[6],
Characterization of the G-types during 2006–2007 Figure 1
Characterization of the G-types during 2006–2007. Distribution of G genotypes (G1 to G4, G8 to G10, mixed [Gmix], 
and non typeable) among children hospitalized with acute rotavirus diarrhea in Salento.BMC Infectious Diseases 2009, 9:43 http://www.biomedcentral.com/1471-2334/9/43
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Rotavirus G/P combinations circulating in Salento during 2006–2007 Figure 3
Rotavirus G/P combinations circulating in Salento during 2006–2007. Percentage of isolation of predominant rotavi-
rus G/P combinations (single types) circulating in Salento during 2006–2007.
Characterization of the P-types during 2006–2007 Figure 2
Characterization of the P-types during 2006–2007. Distribution of P genotypes (P[4], P[6], P[8] to P[11], mixed [Pmix], 
and non typeable) among children hospitalized with acute rotavirus diarrhea in Salento.BMC Infectious Diseases 2009, 9:43 http://www.biomedcentral.com/1471-2334/9/43
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G4P[4], G1P[4] and G2P[6], found in 2.6%, 2%, 1.3%,
1.3%, 0.7% and 0.7%, respectively. Besides, in this study
novel and unusual RV strains, such as G2P[10] (5.9%),
G4P[10] (0.7%), G8P[4] (0.7%), G9P[11] (0.7%) and
G10P[8] (0.7%) were occasionally detected (Figure 3).
Furthermore, a low percentage of mixed infections was
also present during the period 2006–2007, including
17.3% (42/243) among G types and 1.7% (4/243) for P
types (Table 2).
Discussion
The genetic diversity of RV strains circulating in Europe is
also associated with emerging strains that vary between
regions from year to year [9,14].
Molecular analysis of the VP7 gene revealed the preva-
lence of six different G-genotypes in Salento.
In particular, study data from this 2-year investigation
indicates that the G2 rotavirus continue to be the most
prevalent genotype as it was in the previous surveillance
study conducted between 2004–2005 in Salento [11].
Moreover, our study confirmed the persistence of rotavi-
ruses G9, identified in this area since 2004 [11]. Genotype
G9, previously infrequently reported, has become quite
common all over the world [5]. An increased prevalence
of the G9 genotype has also been noted in Italy [15,16].
This result reinforces the possibility that G9 may represent
the fifth globally important genotype to be considered in
vaccination programs.
Furthermore, this study documents the first detection of
G8 and G10 strains in Salento. These strains (normally
associated with animals) have been sporadically recov-
ered from humans in various geographical areas. Geno-
type G8 strains were first reported from young children
with gastroenteritis in Indonesia [17]. Later these rotavi-
ruses were also reported from Finland, Italy, Nigeria, Bra-
zil [18-21] and other parts of the African continent,
especially Malawi [22,23].
RV G10 genotype was first isolated in the UK in 1992 but
recent epidemiological surveys have reported the presence
of this strain in India [24].
With respect to VP4 gene, six different P-types were iden-
tified; P[8] was the prevalent type while P[9], P[10] and
P[11] were detected for the first time in Salento.
At present, worldwide, five common G/P combinations of
RV predominate, namely G1P[8], G2P[4], G3P[8], G4P[8]
and G9P[8] [5, 9, 14]. Global reviews of the main G and
P type combinations encountered in human infections
have identified G1P[8] as the most prevalent type [5].
In this research, only 4 of the most common G/P combi-
nations were identified (no G3P[8] was found), represent-
ing 59.8% of the typeable RV samples. However, G2P[8]
was the most prevalent combination during 2006–2007,
while G1P[8] was predominant one in 2007.
G2P[8] is a new and unusual G/P combination that in
recent years (with G1P[4] and G4P[4]) has been detected
at relatively high frequency from different parts of the
world [5].
The detection of uncommon strains, such as G2P[10],
G4P[10], G8P[4], G9P[11] and G10P[8], is significant.
Finally, according to multiplex PCR results, a lot of mixed
infections, especially in the G-types, were identified. These
mixed infections most likely represent naturally occurring
reassortment among RV strains [4,5,25]. Anyway, the use
of multiplex PCR in the identification of mixed infectious
should be handled with caution. The possibility of unspe-
cific primer binding has to be taken into consideration.
Furthermore, in mixed infections the rotavirus strains
might be present at different concentrations, resulting in
an uneven degree of PCR amplification, making the inter-
pretation of the gel band pattern difficult [26,27].
In light of these considerations, additional experiments
are necessary to confirm the results obtained during G and
Table 2: Distribution of RV mixed infections during 2006–2007
Strains with given genotype
Genotype 2006 2007 2006–2007
n. (%) n. (%) n. (%)
G mixed infections
G1 G2 3 (12%) 7 (41.2%) 10 (23.8%)
G1 G4 3 (12%) - 3 (7.1%)
G1 G9 1 (4%) 3 (17.6%) 4 (9.5%)
G2 G4 2 (8%) 1 (6%) 3 (7.1%)
G2 G8 4 (16%) 3 (17.6%) 7 (16.7%)
G2 G9 6 (24%) 3 (17.6%) 9 (21.4%)
G2 G10 1 (4%) - 1 (2.4%)
G9 G10 1 (4%) - 1 (2.4%)
G1 G2 G8 1 (4%) - 1 (2.4%)
G1 G2 G9 1 (4%) - 1 (2.4%)
G2 G4 G10 1 (4%) - 1 (2.4%)
G2 G9 G10 1 (4%) - 1 (2.4%)
TOTAL 25 17 42
P mixed infections
P[4] P[8] 1 (50%) 2 (100%) 3 (75%)
P[6] P[8] 1 (50%) 1 (25%)
TOTAL 2 2 4
During 2006 there was a greater variability in the G-types than 2007.BMC Infectious Diseases 2009, 9:43 http://www.biomedcentral.com/1471-2334/9/43
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P typing. In particular, the confirmation of the high fre-
quency of unusual G/P combinations found by sequence
analysis is recommended.
Conclusion
The diversity of strains circulating in different regions may
be important for vaccine administration and develop-
ment. Two live oral vaccines have recently been licensed
to protect children against RV diarrhea: Rotateq, a human-
bovine pentavalent vaccine, and Rotarix, a G1P[8] mono-
valent human rotavirus vaccine [28,29].
Clinical trials of these vaccines among children of rich and
middle-income families in different countries have dem-
onstrated high efficacy against the most common RV
strains.
Anyway, the importance of heterotypic protection has to
be fully understood; for this reason, virological surveil-
lance and strain characterization should be implemented.
Post-marketing surveillance studies are needed to monitor
the vaccine impact on circulating strains in order to eval-
uate the immunological pressure obtained by vaccination,
to identify if strain replacement occurs, and to measure
the extent of cross-protection against different RV geno-
types, including G9 (which is becoming increasingly
important in the world) and G8 (whose prevalence is
increasing in different parts of Africa), as these G types
were also detected in Salento.
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